REM-422 Clinical Trials

2 actively recruiting trials across 2 locations

Filter by location:

Duarte, California1 trial

Study of REM-422 in Patients With AML or Higher Risk MDS

City of Hope

Phase 1

San Francisco, California1 trial

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

University of California San Francisco Helen Diller Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.